Impact BioMedical, Inc. — Institutional Ownership
Which tracked institutions hold IBO, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
7
Funds holding
$672750
Total value held
Buying
4 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | State Street Corp | $364738 | 607897 | +596100 | +5052.98% |
| 2 | Blackrock, Inc. | $155968 | 259946 | — | Held |
| 3 | Northern Trust Corp | $146366 | 243943 | +233718 | +2285.75% |
| 4 | Morgan Stanley | $5564 | 9274 | +8 | +0.09% |
| 5 | Wells Fargo & Company/Mn | $113 | 224 | -29 | -11.46% |
| 6 | Citigroup Inc | $1 | 1 | -3395 | -99.97% |
| 7 | Royal Bank Of Canada | $0 | 32 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.